glp-1 based therapeutics summit 3rd 2026 • Biopharma Asia GLP-1-Based Therapeutics Summit

Ozempics success for obesity treatment prompted other drug makers to formulate their own version of GLP-1 receptor agonists

Such transformative outcomes are a powerful motivator for patients struggling with obesity

Impaired Glutathione Synthesis in Neurodegeneration 5

10.1007/s12272-009-1517-2 39 GaoY.LiuM

Key considerations include: The safety profile of weight loss injections in patients with dyslipidaemia Potential interactions with lipid-lowering medications The impact of weight loss itself on cholesterol levels Individual cardiovascular risk assessment Clinical evidence suggests that GLP-1 receptor agonists may have beneficial effects on lipid profiles beyond their primary weight loss action

In parallel, emerging data from male reproductive studies suggest that GLP-1RAs may positively influence the hypothalamic-pituitarytesticular axis, improve testicular function, and enhance spermatogenesis, particularly in obese men